한글목차

세계의 유당불내증 시장 규모는 2024년에 209억 달러에 달하며, 2030년까지 CAGR은 6.70%로, 예측 기간 중 인상적인 성장을 달성할 것으로 예측됩니다.

세계의 유당불내증 시장은 전 세계 유당불내증 유병률 증가와 유당불내증에 대한 소비자의 인식이 높아짐에 따라 최근 수년간 괄목할 만한 성장과 진화를 거듭하고 있습니다. 유당불내증은 유제품에 포함된 당질인 유당을 체내에서 소화하지 못해 복통, 설사, 복부 팽만감 등의 증상을 유발하는 소화기 질환입니다.

그 결과, 대체 우유, 요구르트, 치즈 대체품 등 무유당 및 무유제품에 대한 수요가 증가하여 유당불내증 시장을 발전시키고 있습니다. 이 시장의 주요 촉진요인 중 하나는 유당불내증 유병률 증가이며, 이는 지역에 따라 다르지만 전 세계 인구의 상당 부분이 이 질환을 앓고 있는 것으로 추정됩니다. 유전, 민족성, 식습관 등의 요인이 다양한 유병률에 기여하고 있습니다. 이에 따라 유당불내증을 정확하게 파악할 수 있는 진단 검사의 필요성이 증가하고 있으며, 유당불내증 환자가 유제품을 보다 편안하게 소화할 수 있도록 도와주는 락타아제 보충제에 대한 수요도 급증하고 있습니다. 유당불내증 유병률 증가와 더불어 식습관 선호도 변화, 채식주의 및 식물성 식습관 동향이 유당을 함유하지 않은 대체 식품에 대한 수요를 더욱 증가시키고 있습니다. 이에 따라 식품 및 음료 제조업체들은 유당불내증 환자를 위한 혁신적인 유제품 대체품을 개발하기 위해 연구개발에 투자하고 있으며, 유당불내증 시장이 확대되고 있습니다. 또한 유당불내증에 대한 인식과 교육이 증가함에 따라 개인들이 적절한 식단을 선택하도록 유도하여 유당 무함유 제품 소비가 급증하고 있습니다. 그 결과, 유당불내증 시장은 기존 기업과 신생 기업 모두 제품 개발, 마케팅 및 유통에 대한 막대한 투자를 목격하고 있습니다.

주요 시장 성장 촉진요인

유당불내증의 보급률 상승

주요 시장이 해결해야 할 과제

한정된 진단과 인지

주요 시장 동향

식물 기반 식사와 채식주의

목차

제1장 제품 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 유당불내증 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 유형별(원발성, 연발성, 선천성, 발달성)
  • 진단별(수소 호기 시험, 혈당치 검사, 변산도 검사)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 유당불내증 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 유당불내증 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 유당불내증 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 유당불내증 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 유당불내증 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 합병과 인수

제13장 세계의 유당불내증 시장 : SWOT 분석

제14장 경쟁 구도

• Kshipra Biotech Private Limited
• EMD Serono
• Intoleran
• MACLEODS
• Merck KGaA
• DSM
• Johnson & Johnson Services, Inc
• NOW Foods
• Procter & Gamble
• Chr. Hansen Holding A/S
• Biofermen Private Limited

제15장 전략적 제안

제16장 조사회사 소개·면책사항

영문목차

Global Lactose Intolerance Market was valued at USD 20.90 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.70% through 2030. The global lactose intolerance market has witnessed significant growth and evolution in recent years, driven by a rising prevalence of lactose intolerance worldwide and an increasing awareness of this condition among consumers. Lactose intolerance is a digestive disorder characterized by the body's inability to digest lactose, a sugar found in dairy products, leading to symptoms such as abdominal pain, diarrhea, and bloating.

As a result, there has been a growing demand for lactose-free and dairy-free products, including milk alternatives, yogurt, and cheese substitutes, which has propelled the lactose intolerance market forward. One of the key drivers of this market is the increasing prevalence of lactose intolerance, which varies by region but is estimated to affect a significant portion of the global population. Factors such as genetics, ethnicity, and dietary habits contribute to the varying prevalence rates. Consequently, there is a growing need for diagnostic tests to accurately identify lactose intolerance, as well as a surge in demand for lactase supplements, which help individuals with lactose intolerance digest dairy products more comfortably. In addition to the rising prevalence of lactose intolerance, changing dietary preferences, and the growing trend of veganism and plant-based diets, have further fueled the demand for lactose-free alternatives. This has prompted food and beverage manufacturers to invest in research and development to create innovative dairy substitutes that cater to lactose-intolerant individuals, thereby expanding the lactose intolerance market. Furthermore, increased awareness and education regarding lactose intolerance have encouraged individuals to seek out suitable dietary options, leading to a surge in the consumption of lactose-free products. Consequently, the lactose intolerance market has witnessed substantial investments in product development, marketing, and distribution by both established players and emerging companies.

Key Market Drivers

Rising Prevalence of Lactose Intolerance

The rising prevalence of lactose intolerance has emerged as a significant driver behind the growth of the global lactose intolerance market. Lactose intolerance, a condition impairing the body's ability to digest lactose, affects approximately 65-70% of the global population, presenting a significant market consideration for the dairy and alternative food industries. Prevalence rates vary notably across demographics, with higher incidence observed among Asian, African, and Hispanic populations, underscoring the demand for lactose-free and dairy substitute products in these key consumer segments. Lactose intolerance is no longer a niche concern; instead, it has become a prevalent digestive disorder affecting millions of individuals worldwide. The condition's prevalence varies by region and ethnicity, but it is estimated that a substantial portion of the global population is lactose intolerant. Factors such as genetics, age, and dietary habits contribute to the development of lactose intolerance.

Key Market Challenges

Limited Diagnosis and Awareness

Lactose intolerance, a common digestive disorder affecting millions worldwide, is a condition characterized by the body's inability to properly digest lactose, a sugar found in dairy products. While it has gained recognition in recent years, limited diagnosis and awareness remain significant hurdles hindering the growth of the global lactose intolerance market.

One of the primary challenges facing the lactose intolerance market is the underdiagnosis of this condition. Many individuals who experience symptoms such as abdominal pain, bloating, diarrhea, and gas after consuming dairy products may not recognize these signs as indicators of lactose intolerance. Instead, they may attribute these symptoms to other factors, leading to a delay in diagnosis and treatment.

Key Market Trends

Plant-Based Diets and Veganism

Plant-based diets and veganism have emerged as significant drivers behind the growth of the global lactose intolerance market. These dietary trends, characterized by the avoidance of animal-derived products, including dairy, have created a substantial demand for lactose-free alternatives, which in turn have boosted the lactose intolerance market. Individuals adopting plant-based diets and embracing veganism often seek alternatives to traditional dairy products as they align with their ethical, environmental, and health-conscious beliefs. This shift in dietary preferences has led to a surge in the consumption of plant-based milk alternatives such as almond milk, soy milk, oat milk, and coconut milk, all of which are naturally devoid of lactose.

Moreover, veganism and plant-based diets have contributed to the expansion and diversification of the lactose-free product market. Manufacturers have responded to this trend by introducing a wide array of dairy-free options that cater not only to lactose-intolerant individuals but also to vegans and individuals looking to reduce their dairy consumption.

Key Market Players

• Kshipra Biotech Private Limited
• EMD Serono
• Intoleran
• MACLEODS
• Merck KGaA
• DSM
• Johnson & Johnson Services, Inc
• NOW Foods
• Procter & Gamble
• Chr. Hansen Holding A/S
• Biofermen Private Limited

Report Scope:

In this report, the Global Lactose Intolerance Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lactose Intolerance Market, By Type:

• Primary
• Secondary
• Congenital
• Developmental

Lactose Intolerance Market, By Diagnosis:

• Hydrogen breath test
• Glucose blood test
• Stool acidity test

Lactose Intolerance Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lactose Intolerance Market.

Available Customizations:

Global Lactose Intolerance Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Lactose Intolerance Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Primary, Secondary, Congenital, Developmental)
  • 5.2.2. By Diagnosis (Hydrogen breath test, Glucose blood test, Stool acidity test)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Lactose Intolerance Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Diagnosis
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Lactose Intolerance Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Diagnosis
  • 6.3.2. Canada Lactose Intolerance Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Diagnosis
  • 6.3.3. Mexico Lactose Intolerance Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Diagnosis

7. Europe Lactose Intolerance Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Diagnosis
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Lactose Intolerance Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Diagnosis
  • 7.3.2. United Kingdom Lactose Intolerance Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Diagnosis
  • 7.3.3. Italy Lactose Intolerance Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Diagnosis
  • 7.3.4. France Lactose Intolerance Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Diagnosis
  • 7.3.5. Spain Lactose Intolerance Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Diagnosis

8. Asia-Pacific Lactose Intolerance Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Diagnosis
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Lactose Intolerance Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Diagnosis
  • 8.3.2. India Lactose Intolerance Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Diagnosis
  • 8.3.3. Japan Lactose Intolerance Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Diagnosis
  • 8.3.4. South Korea Lactose Intolerance Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Diagnosis
  • 8.3.5. Australia Lactose Intolerance Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Diagnosis

9. South America Lactose Intolerance Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Diagnosis
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Lactose Intolerance Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Diagnosis
  • 9.3.2. Argentina Lactose Intolerance Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Diagnosis
  • 9.3.3. Colombia Lactose Intolerance Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Diagnosis

10. Middle East and Africa Lactose Intolerance Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Diagnosis
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Lactose Intolerance Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Lactose Intolerance Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Diagnosis
  • 10.3.3. UAE Lactose Intolerance Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Diagnosis

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Lactose Intolerance Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Kshipra Biotech Private Limited
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. EMD Serono
• 14.3. Intoleran
• 14.4. MACLEODS
• 14.5. Merck KGaA
• 14.6. DSM
• 14.7. Johnson & Johnson Services, Inc
• 14.8. NOW Foods
• 14.9. Procter & Gamble
• 14.10.Chr. Hansen Holding A/S
• 14.11.Biofermen Private Limited

15. Strategic Recommendations

16. About Us & Disclaimer